TerrAscend (TSNDF) Other Non-Current Assets (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Other Non-Current Assets of $5.2 million for Q1 2026, up 3002.98% year-over-year from $168000.0 in Q1 2025, and up 8588.33% quarter-over-quarter from $60000.0 in Q4 2025.
TerrAscend (TSNDF) Other Non-Current Assets (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Other Non-Current Assets for 6 consecutive years, with $5.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 3002.98% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (up 3002.98% YoY), while the FY2025 annual figure was $60000.0, down 91.7% from the prior year.
- Other Non-Current Assets grew to $5.2 million in Q1 2026 per TSNDF's latest filing, from $60000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.2 million in Q1 2026 and bottomed at $60000.0 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $724000.0 in 2024.
- Annual changes were most pronounced in 2025 — Other Non-Current Assets sank 91.7% — and 2026, when it surged 3002.98%.
- TerrAscend's Other Non-Current Assets stood at $837000.0 in 2022, then increased by 2.03% to $854000.0 in 2023, then decreased by 15.34% to $723000.0 in 2024, then tumbled by 91.7% to $60000.0 in 2025, then soared by 8588.33% to $5.2 million in 2026.
- Business Quant data shows TSNDF's Other Non-Current Assets at $5.2 million in Q1 2026, $60000.0 in Q4 2025, and $168000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 13.00 Mn |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 733,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 733,000.00 |
| Mar 31, 2026 | 5.21 Mn |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 507,000.00 |
| Mar 31, 2025 | 168,000.00 |
| Dec 31, 2024 | 723,000.00 |
| Sep 30, 2024 | 284,000.00 |
| Jun 30, 2024 | 724,000.00 |
| Mar 31, 2024 | 867,000.00 |
| Dec 31, 2023 | 854,000.00 |
| Sep 30, 2023 | 426,000.00 |
| Jun 30, 2023 | 848,000.00 |
| Mar 31, 2023 | 525,000.00 |
| Dec 31, 2022 | 837,000.00 |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 4.82 Mn |
| Dec 31, 2021 | 3.14 Mn |